Denali Therapeutics Inc (NAS:DNLI)
$ 18.56 0.13 (0.7%) Market Cap: 2.65 Bil Enterprise Value: 1.76 Bil PE Ratio: 0 PB Ratio: 1.82 GF Score: 58/100

Denali Therapeutics Inc (DNLI) Transcripts

  • 1